Day: February 12, 2021

Tauriga Sciences, Inc. Now Configured to Accept the Following Cryptocurrencies as Payment Options on Its E-Commerce Platform: Bitcoin (BTC), Etherium (ETH), Bitcoin Cash (BCH), Dai (DAI), and Litecoin (LTC)

Written by Customer Service on . Posted in Public Companies.

The Acceptance of Bitcoin, and These Other Select Cryptocurrencies, Will Improve the Company’s Ability to Transact with Its Global Customer BaseNEW YORK, NY, Feb. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, today announced that it is now configured to accept the following cryptocurrencies as payment options on its E-Commerce Platform (www.taurigum.com): Bitcoin (“BTC”), Etherium (“ETH”), Bitcoin Cash (“BCH”), Dai (“DAI”), and Litecoin (“LTC”).  As the Company continues to grow its...

Continue reading

Calvin B. Taylor Bankshares, Inc. (OTCQX: TYCB), Parent Company of Calvin B. Taylor Bank, Today Announced that Its Board of Directors has Elected Hale Harrison as Chair of the Board of Directors of the Company and the Bank

Written by Customer Service on . Posted in Public Companies.

BERLIN, MD, Feb. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Calvin B. Taylor Bankshares, Inc. (the “Company”) (OTCQX: TYCB), parent company of Calvin B. Taylor Bank (the “Bank”), today announced that its Board of Directors has elected Hale Harrison as Chair of the Board of Directors of the Company and the Bank.    Mr. Harrison joined the Company’s Board of Directors in October 1995 and the Bank’s Board of Directors in 1975.  He owns and operates Harrison Group Resort Hotels in Ocean City, Maryland. Mr. Harrison is a former Councilman and Secretary for the Town of Ocean City, and former Chairman of the Ocean City Planning and Zoning Commission.  He is also a past Chairman and member of the Finance Committee of the Board of Trustees of Atlantic General Hospital.In addition to serving as Chair of the Board of Directors of the...

Continue reading

Fidus Investment Corporation Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call

Written by Customer Service on . Posted in Public Companies.

EVANSTON, Ill., Feb. 12, 2021 (GLOBE NEWSWIRE) — Fidus Investment Corporation (NASDAQ: FDUS) (“Fidus” or the “Company”) today announced that it will report its fourth quarter and full year 2020 financial results on Thursday, February 25, 2021 after the close of the financial markets.Management will host a conference call to discuss the operating and financial results at 9:00am ET on Friday, February 26, 2021. To participate in the conference call, please dial (877) 810-3368 approximately 10 minutes prior to the call. International callers should dial (914) 495-8561. Please reference conference ID # 9295560.A live webcast of the conference call will be available at http://investor.fdus.com/events-presentations. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software.A...

Continue reading

Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation and Cellular Therapy Meetings Digital Experience

Written by Customer Service on . Posted in Public Companies.

Higher dose cohorts demonstrated 100% overall response rate, resulting in substantial reduction in baseline corticosteroid useDose-dependent reduction of CD6 expression on CD4+ and CD8+ T cells is consistent with itolizumab mechanism of actionLA JOLLA, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, presented interim data from the EQUATE clinical trial supporting itolizumab’s potential as a first-line treatment for acute graft-versus-host disease (aGVHD). The study, described in the late-breaking oral presentation titled “Preliminary Safety and Efficacy of Itolizumab, A Novel Targeted Anti-CD6 Therapy, in Newly Diagnosed Severe Acute Graft-Versus-Host Disease: Interim Results from Equate Study,”...

Continue reading

ANNOUNCEMENT OF A CHANGE IN SHAREHOLDING ACCORDING TO CHAPTER 9, SECTION 10 OF THE FINNISH SECURITIES MARKET ACT

Written by Customer Service on . Posted in Public Companies.

Rapala VMC CorporationStock Exchange ReleaseFebruary 12, 2021 at 10:00 p.m.ANNOUNCEMENT OF A CHANGE IN SHAREHOLDING ACCORDING TO CHAPTER 9, SECTION 10 OF THE FINNISH SECURITIES MARKET ACTRapala VMC Corporation has received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Sofina SA (Brussels, Belgium) on 12.2.2021.According to the notification, the aggregate ownership of Sofina SA in Rapala VMC Corporation’s shares (ISIN: FI0009007355) decreased below five (5) per cent threshold on February 11, 2021.Rapala VMC Corporation has one share series, and each share entitles its holder to one (1) vote. The total number of shares is 39,000,000.Total positions of person(s) subject to the notification obligation:Notified details of the resulting situation on the date on which the threshold was crossed:A: Shares and...

Continue reading

ARVOPAPERIMARKKINALAIN 9 LUVUN 10 PYKÄLÄSSÄ TARKOITETTU ILMOITUS

Written by Customer Service on . Posted in Public Companies.

Rapala VMC OyjPörssitiedote12.2.2021 klo 22.00ARVOPAPERIMARKKINALAIN 9 LUVUN 10 PYKÄLÄSSÄ TARKOITETTU ILMOITUSRapala VMC Oyj on 12.2.2021 vastaanottanut arvopaperimarkkinalain 9 luvun 5 §:n mukaisen ilmoituksen Sofina SA:lta (Bryssel, Belgia).Ilmoituksen mukaan Sofina SA:n yhteenlaskettu omistusosuus Rapala VMC Oyj:n osakkeista (ISIN: FI0009007355) laski alle viiden (5) prosentin 11.2.2021.Rapala VMC Oyj:llä on yksi osakesarja, jossa kullakin osakkeella on yksi ääni. Osakkeiden kokonaismäärä on 39.000.000.Liputusvelvollisen (liputusvelvollisten) osuus:Tiedot omistus- ja ääniosuudesta liputusrajan saavuttamisen tai rikkoutumisen jälkeen:A: Osakkeet ja äänetB: AML:n 9 luvun 6 a §:ssä tarkoitetut rahoitusvälineetEi ilmoitettujaTietoja liputusvelvollisestaLiputusvelvollinen ei ole minkään luonnollisen henkilön tai oikeushenkilön määräysvallassa...

Continue reading

ANNOUNCEMENT OF A CHANGE IN SHAREHOLDING ACCORDING TO CHAPTER 9, SECTION 10 OF THE FINNISH SECURITIES MARKET ACT

Written by Customer Service on . Posted in Public Companies.

Rapala VMC CorporationStock Exchange ReleaseFebruary 12, 2021 at 10:00 p.m.ANNOUNCEMENT OF A CHANGE IN SHAREHOLDING ACCORDING TO CHAPTER 9, SECTION 10 OF THE FINNISH SECURITIES MARKET ACTRapala VMC Corporation has received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Sycamore Partners Management, L.P. (New York, U.S.) on 12.2.2021.According to the notification, the aggregate ownership of Cermak Road LLC in Rapala VMC Corporation’s shares (ISIN: FI0009007355) increased above fifteen (15) per cent threshold on February 11, 2021.Rapala VMC Corporation has one share series, and each share entitles its holder to one (1) vote. The total number of shares is 39,000,000.Total positions of person(s) subject to the notification obligation:Notified details of the resulting situation on the date on which the threshold...

Continue reading

ARVOPAPERIMARKKINALAIN 9 LUVUN 10 PYKÄLÄSSÄ TARKOITETTU ILMOITUS

Written by Customer Service on . Posted in Public Companies.

Rapala VMC OyjPörssitiedote12.2.2021 klo 22.00ARVOPAPERIMARKKINALAIN 9 LUVUN 10 PYKÄLÄSSÄ TARKOITETTU ILMOITUSRapala VMC Oyj on 12.2.2021 vastaanottanut arvopaperimarkkinalain 9 luvun 5 §:n mukaisen ilmoituksen Sycamore Partners Management, L.P.:ltä (New York, Yhdysvallat).Ilmoituksen mukaan Cermak Road LLC:n yhteenlaskettu omistusosuus Rapala VMC Oyj:n osakkeista (ISIN: FI0009007355) nousi yli viidentoista (15) prosentin 11.2.2021.Rapala VMC Oyj:llä on yksi osakesarja, jossa kullakin osakkeella on yksi ääni. Osakkeiden kokonaismäärä on 39.000.000.Liputusvelvollisen (liputusvelvollisten) osuus:Tiedot omistus- ja ääniosuudesta liputusrajan saavuttamisen tai rikkoutumisen jälkeen:A: Osakkeet ja äänetB: AML:n 9 luvun 6 a §:ssä tarkoitetut rahoitusvälineetEi ilmoitettujaTietoja liputusvelvollisestaKoko määräysvaltaketju (ylintä määräysvaltaa...

Continue reading

AMMO, Inc. Provides Corporate Update and Earnings Call Reminder

Written by Customer Service on . Posted in Public Companies.

SCOTTSDALE, Ariz., Feb. 12, 2021 (GLOBE NEWSWIRE) — AMMO, Inc. (Nasdaq: POWW ) (“AMMO” or the “Company”), a premier American ammunition and munition components manufacturer and technology leader, is pleased to provide a corporate update from the Company’s Chairman and CEO.Our Company has seen tremendous growth over the last 12 months. As our team continues to strive to reach higher goals, we feel it is important to provide an update to our investors in order to keep everyone abreast of the execution on our daily commitment to enhance shareholder value and grow this Company. Today’s update is meant as a progress report regarding where we are today, and where we hope to be by the end of our 2021 fiscal year as of March 31, 2021.Signed a Letter of Intent on February 9th to acquire GunBroker.com at an enterprise value of $240 million.GunBroker.com...

Continue reading

Claren Energy Unaware of Any Material Change

Written by Customer Service on . Posted in Public Companies.

TORONTO, Feb. 12, 2021 (GLOBE NEWSWIRE) — At the request of IIROC, Claren Energy Corp. (“Claren” or the “Company”) (TSX-V: CEN) wishes to confirm that the Company’s management is unaware of any material change in the Company’s operations that would account for the recent increase in market activity.About Claren Energy Corp.Claren Energy Corp. is an oil and gas company that has a (100%) participating interest in the Bobocu Production License, onshore Romania. Its common shares trade on the TSX Venture Exchange under the symbol “CEN”.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.This news release may contain assumptions, estimates, and other forward-looking statements...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.